By Conjoint Professor Dedee Frances Murrell

Journal articles

Murrell DF; Yamagami J, 2026, 'The plot thickens in pemphigus: New therapeutic targets from state-of-the-art ex vivo assays', Journal of Investigative Dermatology, 146, pp. 876 - 878, http://dx.doi.org/10.1016/j.jid.2026.01.001

Dulai AS; Murase EM; Avallone G; Ferrucci SM; Marzano AV; Ribero S; Ardern-Jones M; Ko E; Flohr C; Leshem YA; Deleuran M; Vestergaard C; Hijnen DJ; Bras J; Elman SA; Pruneddu S; Butler D; Chovatiya R; Girolomoni G; Golant AK; Kamsteeg M; Luna PC; Murrell DF; Stark M; Torres T; Yildrim EA; Aractingi S; Bangert C; Batchelor R; Chen KY; Irvine AD; Lullo JJ; Martin LK; Maul JT; Pérez B; Rosmarin D; Sansom JE; Schultz B; Shipman A; Silverberg NB; Szalai Z; Fodor A; Tanaka AA; Viola K; Sivamani RK; Murase JE, 2026, 'International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes', Journal of the American Academy of Dermatology, 94, pp. 936 - 940, http://dx.doi.org/10.1016/j.jaad.2025.10.123

Syed A; Sarsam S; Murrell DF, 2026, 'Dual control of chronic plaque psoriasis and pouchitis with tildrakizumab', Clinical and Experimental Dermatology, 51, pp. 313 - 314, http://dx.doi.org/10.1093/ced/llaf468

Tseng H; Frew JW; Murrell DF, 2026, 'Viral infections as triggers in autoimmune blistering diseases: A systematic review of associations and mechanisms', Jaad International, 24, pp. 132 - 133, http://dx.doi.org/10.1016/j.jdin.2025.09.007

Nanda A; Tedbirt B; Bodemer C; Bolling MC; El Hachem M; Nikolić M; Benton E; Caproni M; De D; Didona D; Drenovska K; Goebeler M; Hertl M; Horváth B; Kasperkiewicz M; Kiritsi D; Larralde M; Marzano AV; Meijer J; Murrell DF; Powell J; Sprecher E; Chandran NS; Tomayko MM; Uzun S; van Beek N; Ott H; Patsatsi A; Torrelo A; Welfringer-Morin A; Schmidt E; Joly P, 2026, 'European S2k guidelines on management of autoimmune blistering diseases in children and adolescents', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70308

Walter S; Martin LK; Murrell DF, 2026, 'Gender balance at international medical congresses: The EADV congress example, 2015–2023', Journal of the European Academy of Dermatology and Venereology, http://dx.doi.org/10.1111/jdv.70386

Murrell DF; Bodemer C; Bruckner AL; Cunningham T; Davis C; Fernández MF; Kiritsi D; Maher L; Sprecher E; Torres-Pradilla M; Kern JS, 2026, 'Methodological concerns in the EASE study of Oleogel-S10 for epidermolysis bullosa: reply from authors', British Journal of Dermatology, 194, pp. 175 - 177, http://dx.doi.org/10.1093/bjd/ljaf365

Syed A; Khan MT; Murrell DF, 2026, 'Nail Dystrophy Treated With Marigold Therapy in a Patient With Epidermolysis Bullosa Simplex', Australasian Journal of Dermatology, http://dx.doi.org/10.1111/ajd.70086

Korte EWH; Hiel MAJ; Bolling MC; Dunn P; Murrell DF; Werth VP; Yale M; Spuls PI; Meijer JM; Horváth B, 2026, 'Navigating challenges in clinical trials for bullous pemphigoid and pemphigus: learnings from the clinical trial graveyard and an international expert survey', British Journal of Dermatology, 194, pp. 165 - 167, http://dx.doi.org/10.1093/bjd/ljaf366

Chernyshov PV; Finlay AY; Patsatsi A; Marinović B; Salavastru C; Murrell DF; Tomas-Aragones L; Poot F; Pustisek N; Svensson A; Marron SE; Sampogna F; Bewley A; Koumaki D; Suru A; Abeni D; Salek SS; Gregoriou S; Antiga E; Werth VP; Augustin M; Szepietowski JC; Schmidt E, 2026, 'Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering Diseases', International Journal of Dermatology, 65, pp. 18 - 27, http://dx.doi.org/10.1111/ijd.17964

Zhou AE; Sloan B; Murrell DF; Grant-Kels JM, 2026, 'Response to Hassan and Paas, “Curbing paper mills in departments and journals”', Journal of the American Academy of Dermatology, 94, pp. e61 - e62, http://dx.doi.org/10.1016/j.jaad.2025.09.071

Akbarialiabad H; Parvar SY; Grada A; Bunick CG; Shimada K; Melin MM; Taghrir MH; Crucian B; Costes SV; Sanders LM; Paller A; Leachman SA; Alavi A; Lehman JS; El-Hamdi NS; Christiansen R; Tarbox M; Grant-Kels JM; Mostaghimi A; West C; Goldust M; Keshtmand G; Mesinkovska NA; Sadeghian N; Beheshti A; Murrell DF, 2026, 'Space-related dermatoses', Clinics in Dermatology, 44, pp. 87 - 99, http://dx.doi.org/10.1016/j.clindermatol.2025.10.006

Patzelt S; Engin RM; Drenovska K; Kiehne C; Probst C; Komorowski L; Mindorf S; Daneshpazhooh M; Kim SC; Farnetani F; Vaschieri C; Rao R; Marzano AV; Dmochowski M; Patsatsi A; Murrell D; Kern JS; Karakök Kışla H; Sprecher E; De D; Di Zenzo G; Borradori L; Jedlickova H; Zhu X; Schmidt E; Goletz S, 2026, 'Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study', British Journal of Dermatology, 194, pp. 163 - 165, http://dx.doi.org/10.1093/bjd/ljaf385

Baird J; Murrell D, 2025, 'P22 Using VECTRA and AI analysis to monitor paediatric lesions: a review of cases', British Journal of Dermatology, 193, http://dx.doi.org/10.1093/bjd/ljaf465.030

Akbarialiabad H; Schmidt E; Patsatsi A; Lim YL; Mosam A; Tasanen K; Yamagami J; Daneshpazhooh M; De D; Cardones ARG; Joly P; Murrell DF, 2025, 'Author Correction: Bullous pemphigoid (Nature Reviews Disease Primers, (2025), 11, 1, (12), 10.1038/s41572-025-00595-5)', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00605-6

Akbarialiabad H; Schmidt E; Patsatsi A; Lim YL; Mosam A; Tasanen K; Yamagami J; Daneshpazhooh M; De D; Cardones ARG; Joly P; Murrell DF, 2025, 'Bullous pemphigoid', Nature Reviews Disease Primers, 11, http://dx.doi.org/10.1038/s41572-025-00595-5

Cascio Ingurgio R; Alfano A; Matteodo E; Stark M; Valenti M; Narcisi A; Costanzo A; Murrell DF, 2025, 'Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation', Australasian Journal of Dermatology, 66, pp. 468 - 474, http://dx.doi.org/10.1111/ajd.14592

Gooderham M; Torres T; Imafuku S; Rademaker M; Prajapati VH; Tsianakas A; Murrell DF; Owczarek W; Han Y; Lee WJ; Levy G; Ibrahim N; Moreira A; Shams K, 2025, 'Efficacy and safety of upadacitinib dose escalation and reduction in adults with moderate-to-severe atopic dermatitis: Results of a randomized blinded treat-to-target multicentre phase IIIb/IV study (Flex Up)', British Journal of Dermatology, 193, pp. 1101 - 1111, http://dx.doi.org/10.1093/bjd/ljaf236

Akbarialiabad H; Pasdar A; Murrell DF; Mostafavi M; Shakil F; Safaee E; Leachman SA; Haghighi A; Tarbox M; Bunick CG; Grada A, 2025, 'Enhancing randomized clinical trials with digital twins', Npj Systems Biology and Applications, 11, http://dx.doi.org/10.1038/s41540-025-00592-0

Akbarialiabad H; Salehi S; Murrell DF; Jafferany M, 2025, 'Morgellons disease: a review on current evidence and the need for consensus, standardized criteria, and future randomized controlled trials', Archives of Dermatological Research, 317, http://dx.doi.org/10.1007/s00403-025-04308-6

Lee H; Cowan TL; Huang C; Wilson A; Koszegi B; Stone C; Ng J; Sarsam S; Akbarialiabad H; Johal JS; Murrell OGC; Wittal RA; Murrell DF; Daniel BS, 2025, 'Pilot Study of Tildrakizumab in the Treatment of Stable Non-Segmental Vitiligo', JEADV Clinical Practice, 4, pp. 1140 - 1145, http://dx.doi.org/10.1002/jvc2.70113

Murrell DF, 2025, 'Pioneers in Dermatology and Venereology: An interview with Professor Dedee F. Murrell', Journal of the European Academy of Dermatology and Venereology, 39, pp. 2032 - 2036, http://dx.doi.org/10.1111/jdv.70132

Heyworth A; Stark M; Murrell D, 2025, 'Scoring systems for Mucous Membrane Pemphigoid – A review of the literature', SKINdeep, 1, http://dx.doi.org/10.1553/skindeep.2025.162540

Akbarialiabad H; Pasdar A; Murrell DF; Mostafavi M; Shakil F; Safaee E; Leachman SA; Haghighi A; Tarbox M; Bunick CG; Grada A, 2025, 'Erratum: Author Correction: Enhancing randomized clinical trials with digital twins (NPJ systems biology and applications (2025) 11 1 DOI: 10.1038/s41540-025-00592-0.)', Npj Systems Biology and Applications, 11, pp. 124, http://dx.doi.org/10.1038/s41540-025-00609-8

Syed A; Sarsam S; Serquina B; Murrell DF, 2025, 'A review of scoring instruments for the assessment of disease severity in epidermolysis bullosa acquisita', Dermatologica Sinica, 43, pp. 259 - 266, http://dx.doi.org/10.4103/ds.DS-D-25-00105

Sarsam S; He A; Murrell DF, 2025, 'Ofatumumab for the management of refractory pemphigus vulgaris: A case series', Jaad International, 22, pp. 94 - 96, http://dx.doi.org/10.1016/j.jdin.2025.05.018

Stark M; Lara Rivero AD; Murrell DF, 2025, 'Photoallergic drug eruption secondary to oral terbinafine prescribed for management of tinea incognita', SKINdeep, 1, http://dx.doi.org/10.1553/skindeep.2025.153393

Wong PC; Akbarialiabad H; Wang MA; Ng TJ; Wilson A; Shulruf B; Murrell DF, 2025, 'Evaluation of the responsiveness of the Keratosis Pilaris Investigator Global Assessment Score (KP-IGA) and composite KP Area Index (KPAI)', British Journal of Dermatology, 193, pp. 556 - 558, http://dx.doi.org/10.1093/bjd/ljaf163

Aung T; Noakes R; Kasem K; Murrell DF, 2025, 'Linear Focal Elastosis: What We Know From Epidemiological Studies', Australasian Journal of Dermatology, 66, pp. 364 - 368, http://dx.doi.org/10.1111/ajd.14569

Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Murrell DF; Pustisek N; Svensson A; Marron SE; Sampogna F; Bewley A; Salavastru C; Koumaki D; Suru A; Yordanova IA; Zemskov S; Tsymbaliuk R; Ostapko O; Augustin M; Abeni D; Szepietowski JC; Jemec GB, 2025, 'Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts', International Journal of Dermatology, 64, pp. 1546 - 1557, http://dx.doi.org/10.1111/ijd.17668

Bruckner AL; Murrell D; Lee LW; Sprecher E; Kiritsi D; Maher L; Löwe S; Donovan M; Kern JS, 2025, 'Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa—Impact of Oleogel-S10', Journal of Dermatology, 52, pp. 1447 - 1451, http://dx.doi.org/10.1111/1346-8138.17884

Niknam N; Akbarialiabad H; Farjoud Kouhanjani M; Kolaparambil Varghese LJ; Berrington de González A; Melin MM; Shafie’ei M; Mousavi SM; Hosseini SA; Taha SR; Russomano T; Murrell DF; Grada A; Leachman SA; Akbari Z; Derisi AJ; Jurga M; Kumar A; Das S; D’Urbano J; Hakim G; Sadeghian N; Paydar S; Tarbox M; West C; Ghorashi SM; Hosseini SH; Squire T; Bunick CG; Christiansen R, 2025, 'Space Oncology: A Comprehensive Scoping Review', Wilderness and Environmental Medicine, 36, pp. 148 - 171, http://dx.doi.org/10.1177/10806032251349442

Murrell D, 2025, 'Dr. Dedee Murrell', The Nishinihon Journal of Dermatology, 87, pp. 369 - 370, http://dx.doi.org/10.2336/nishinihonhifu.87.369

Sarsam S; Stevenson A; Murrell DF, 2025, 'The Efficacy of Using Oral Sodium Cromoglycate for Controlling Epidermolysis Bullosa-Related Pruritus', Australasian Journal of Dermatology, 66, pp. 309 - 311, http://dx.doi.org/10.1111/ajd.14530

Cascio Ingurgio R; Alfano A; Gargiulo L; Ibba L; Narcisi A; Satgé F; Stark M; Costanzo A; Murrell DF, 2025, 'Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two Centres', Australasian Journal of Dermatology, 66, pp. 305 - 308, http://dx.doi.org/10.1111/ajd.14532

Sarsam S; Koszegi BJ; Murrell DF, 2025, 'Colchicine as a treatment option for inherited epidermolysis bullosa', Clinical and Experimental Dermatology, 50, pp. 1238 - 1240, http://dx.doi.org/10.1093/ced/llaf016

Murrell DF; Bodemer C; Bruckner AL; Cunningham T; Davis C; Fernández MF; Kiritsi D; Maher L; Sprecher E; Torres-Pradilla M; Kern JS, 2025, 'Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study', British Journal of Dermatology, 192, pp. 1007 - 1017, http://dx.doi.org/10.1093/bjd/ljaf022

Salamon G; Strobl S; Field-Werners U; Welponer T; Murrell DF; Diem A, 2025, 'Translation, cultural adaptation and validation of the German Quality of Life in Epidermolysis Bullosa (QOLEB) questionnaire', Journal of Health Psychology, 30, pp. 1476 - 1490, http://dx.doi.org/10.1177/13591053231221369

Akbarialiabad H; Jamshidi P; Callen JP; Murrell DF, 2025, 'Dermatologic manifestations of hereditary hemochromatosis: A systematic review', Journal of the European Academy of Dermatology and Venereology, 39, pp. 976 - 986, http://dx.doi.org/10.1111/jdv.20098

Tanemura C; Nunotani M; Kawabata K; Morooka Y; Yamagami J; Kakuta R; Saito Y; Kurihara Y; Takahashi H; Ishii N; Koga H; Nakama T; Hayashi D; Hiroyasu S; Tateishi C; Tsuruta D; Murrell DF; Hashimoto T, 2025, 'Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires', Journal of Dermatology, 52, pp. 812 - 830, http://dx.doi.org/10.1111/1346-8138.17707

Akbarialiabad H; Jamshidi P; Aminzade Z; Azizi N; Taha SR; Sadeghian N; Varghese LJK; Kouhanjani MF; Niknam N; Babocs D; El-Assaad F; Russomano T; Murrell DF; Paydar S; Bunick CG; Christiansen R; Mark Melin M, 2025, 'Leveraging space innovations for cancer breakthroughs on Earth', Trends in Cancer, 11, pp. 433 - 440, http://dx.doi.org/10.1016/j.trecan.2025.02.003

Yang A; Sarsam S; Murrell DF, 2025, 'Linear IgA Bullous Dermatosis in Adults and Children: A Narrative Review of Literature on Disease Distribution and Evaluation of Existing Scoring Tools', Acta Dermatovenerologica Croatica ADC, 33, pp. 1 - 8

Wang MA; Wilson A; Boucher D; Johal JS; Rosenthal NK; Cowan T; Koszegi B; Lara Rivero AD; Daniel BS; Martin LK; Kern JS; Murrell DF, 2025, 'The development and validation of an investigator global assessment score for keratosis pilaris', Journal of the European Academy of Dermatology and Venereology, 39, pp. e350 - e352, http://dx.doi.org/10.1111/jdv.20326

Karakioulaki M; Dunn P; Murrell DF; Payne A; Schmidt E; Werth V; Yale M; Yamagami J; Aoki V; Borradori L; Caux F; Culton D; Daneshpazhooh M; De D; Fairley J; Hammers C; Hertl M; Holtsche M; Joly P; Koga H; Maverakis E; Mosam A; Pan M; Pincelli C; Saleh MA; Sinha AA; Solimani F; Sprecher E; Tasanen K; Tull TJ; Van Beek N; Vielmuth F; Yayli S; Patsatsi A, 2025, 'Advances in Pemphigus and Pemphigoid: A Report of the International Meeting of the Pemphigus and Pemphigoid Foundation in Thessaloniki, Greece', Jid Innovations, 5, http://dx.doi.org/10.1016/j.xjidi.2024.100339

Walter S; Murrell DF; Pratama R; Kizny Gordon AE; McIver CJ, 2025, 'Assessment of a Real-Time PCR Assay for the Detection of Dermatophytosis by Sampling With an Adhesive Tape Technique', Australasian Journal of Dermatology, 66, pp. e60 - e61, http://dx.doi.org/10.1111/ajd.14415

Zhou AE; Jain NP; Gronbeck C; Sloan B; Murrell DF; Grant-Kels JM, 2025, 'Ethics of publication mills and payment for guaranteed authorships', Journal of the American Academy of Dermatology, 92, pp. 666 - 667, http://dx.doi.org/10.1016/j.jaad.2024.10.034

Walter S; Murrell DF, 2025, 'Toward gender equity for all members of the academic dermatology community', Clinics in Dermatology, 43, pp. 248 - 250, http://dx.doi.org/10.1016/j.clindermatol.2025.01.004

He A; Koszegi B; Uzun S; Bilgic A; Bozca BC; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Kakuta R; Takahashi H; Nery D; Mundin C; Ramirez-Quizon M; Culton D; McAlpine S; Johal J; Shulruf B; Stone JH; Murrell DF, 2025, 'Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathy', Journal of the European Academy of Dermatology and Venereology, 39, pp. 340 - 349, http://dx.doi.org/10.1111/jdv.20149

Murrell DF, 2025, 'Body image disturbance has severe psychosocial impacts in patients suffering from autoimmune blistering diseases', Journal of the European Academy of Dermatology and Venereology, 39, pp. 253 - 254, http://dx.doi.org/10.1111/jdv.20491

Werth VP; Murrell DF; Joly P; Ardeleanu M; Hultsch V, 2025, 'Bullous pemphigoid burden of disease, management and unmet therapeutic needs', Journal of the European Academy of Dermatology and Venereology, 39, pp. 290 - 300, http://dx.doi.org/10.1111/jdv.20313

Back to profile page